Watanabe Todd — SEC Form 4 filings
SEC reporting owner CIK 1801061. 25 Form 4 filings on record with FilingPulse; latest filed 2026-08-05.
Transaction summary — filings shown
Covers all 25 filings on record, filed 2024-01-17 to 2026-08-05. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): 2 legs across 1 filing — 6,038 shares, $21,250 total (shares × price as filed).
- Open-market sales (code S, non-derivative): 29 legs across 21 filings — 368,096 shares, $7,289,517 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 18.
- Largest priced transaction: sale of 48,945 shares @ $30.36 ($1,485,755) in Arcutis Biotherapeutics, Inc., filed 2025-11-24.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| Arcutis Biotherapeutics, Inc. (ARQT) | See Remarks, Director | 25 | 2 legs · 6,038 sh · $21,250 | 29 legs · 368,096 sh · $7,289,517 | 18 |
Form 4 filings — Watanabe Todd
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-08-05 | 4 | Arcutis Biotherapeutics, Inc. (ARQT) | Sale (S): 4,375 @ $26.12 | EDGAR |
| 2026-05-06 | 4 | Arcutis Biotherapeutics, Inc. (ARQT) | Sale (S): 3,172 @ $23.61 | EDGAR |
| 2026-03-03 | 4 | Arcutis Biotherapeutics, Inc. (ARQT) | Grant/award (A): 102,000 @ $0 · Sale (S): 36,281 @ $25.16 · Sale (S): 1,068 @ $25.91 · Grant/award (A): 266,000 (derivative) @ $0 | EDGAR |
| 2026-02-04 | 4 | Arcutis Biotherapeutics, Inc. (ARQT) | Sale (S): 19,833 @ $25.50 | EDGAR |
| 2025-11-24 | 4 | Arcutis Biotherapeutics, Inc. (ARQT) | Sale (S): 1,055 @ $30 · Sale (S): 48,945 @ $30.36 | EDGAR |
| 2025-11-05 | 4 | Arcutis Biotherapeutics, Inc. (ARQT) | Sale (S): 11,478 @ $24.71 · Sale (S): 69 @ $25.40 | EDGAR |
| 2025-10-30 | 4 | Arcutis Biotherapeutics, Inc. (ARQT) | Sale (S): 40,000 @ $25.03 | EDGAR |
| 2025-10-03 | 4 | Arcutis Biotherapeutics, Inc. (ARQT) | Sale (S): 15,000 @ $18.91 · Sale (S): 9,261 @ $20.02 · Sale (S): 20,739 @ $20.04 | EDGAR |
| 2025-09-10 | 4 | Arcutis Biotherapeutics, Inc. (ARQT) | Sale (S): 9,625 @ $17.54 · Sale (S): 504 @ $17.52 | EDGAR |
| 2025-08-05 | 4 | Arcutis Biotherapeutics, Inc. (ARQT) | Sale (S): 11,547 @ $14.33 | EDGAR |
| 2025-06-12 | 4 | Arcutis Biotherapeutics, Inc. (ARQT) | Gift (G): 997 @ $0 · Gift (G): 997 @ $0 · Gift (G): 997 @ $0 · Gift (G): 997 @ $0 | EDGAR |
| 2025-05-05 | 4 | Arcutis Biotherapeutics, Inc. (ARQT) | Sale (S): 11,448 @ $15.19 | EDGAR |
| 2025-03-26 | 4 | Arcutis Biotherapeutics, Inc. (ARQT) | Sale (S): 1,500 @ $17.52 · Sale (S): 2,171 @ $17.56 | EDGAR |
| 2025-03-20 | 4 | Arcutis Biotherapeutics, Inc. (ARQT) | Sale (S): 1,200 @ $17.61 | EDGAR |
| 2025-03-04 | 4 | Arcutis Biotherapeutics, Inc. (ARQT) | Grant/award (A): 151,000 @ $0 · Sale (S): 20,880 @ $13.03 · Sale (S): 4,135 @ $13.28 · Grant/award (A): 396,000 (derivative) @ $0 | EDGAR |
| 2025-02-04 | 4 | Arcutis Biotherapeutics, Inc. (ARQT) | Sale (S): 19,301 @ $12.70 | EDGAR |
| 2024-12-23 | 4 | Arcutis Biotherapeutics, Inc. (ARQT) | Sale (S): 15,000 @ $15.17 | EDGAR |
| 2024-12-03 | 4 | Arcutis Biotherapeutics, Inc. (ARQT) | Purchase (P): 4,000 @ $1.69 · Purchase (P): 2,038 @ $7.11 | EDGAR |
| 2024-11-05 | 4 | Arcutis Biotherapeutics, Inc. (ARQT) | Sale (S): 13,871 @ $8.68 | EDGAR |
| 2024-08-05 | 4 | Arcutis Biotherapeutics, Inc. (ARQT) | Sale (S): 14,487 @ $9.02 | EDGAR |
| 2024-05-03 | 4 | Arcutis Biotherapeutics, Inc. (ARQT) | Sale (S): 13,783 @ $8.74 | EDGAR |
| 2024-03-06 | 4 | Arcutis Biotherapeutics, Inc. (ARQT) | Sale (S): 14,903 @ $11.12 | EDGAR |
| 2024-03-01 | 4 | Arcutis Biotherapeutics, Inc. (ARQT) | Sale (S): 2,465 @ $10.60 | EDGAR |
| 2024-02-15 | 4 | Arcutis Biotherapeutics, Inc. (ARQT) | Grant/award (A): 21,666 · Grant/award (A): 33,066 · Grant/award (A): 94,050 · Grant/award (A): 116,100 · Disposition to issuer (D): 65,000 (derivative) · Disposition to issuer (D): 99,200 (derivative) · +2 more | EDGAR |
| 2024-01-17 | 4 | Arcutis Biotherapeutics, Inc. (ARQT) | Grant/award (A): 125,000 @ $0 · Grant/award (A): 410,000 (derivative) @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1801061 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →